Zensar Technologies Limited — Board Meeting, 22-10-2024: Outcome of Board Meeting

Zensar Technologies Limited's Board has approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2024. Revenue from operations reached ₹5,562 million for Q2 2024, showcasing a year-on-year increase. The net profit for the quarter amounted to ₹1,517 million. Additionally, the company confirmed the acquisition of BridgeView Life Sciences, reflecting a strategic expansion in technology consulting services. The trading window for securities will reopen shortly.